Affiliation:
1. Department of Medicine, University of Illinois at Chicago 60612, USA.
Abstract
Antituberculosis activity of clarithromycin (CLA), a macrolide antibiotic, was investigated in vitro, in macrophages, and in C57BL/6 mice, CLA showed high in vitro MICs (4 to > 16 micrograms/ml) for several strains of Mycobacterium tuberculosis and caused slight enhancement of activity of rifampin (RIF) against H37Rv but failed to increase the activity of either RIF or isoniazid (INH) against other strains. However, inside J774A.1 macrophages, CLA showed high activity and was synergistic with RIF against some strains of tubercle bacilli susceptible or resistant to INH and RIF. In the in vivo studies with a drug-susceptible strain (H37Rv), CLA protected mice from mortality due to tuberculosis for up to 8 weeks of observation. The CFU data for lungs and spleens revealed that the antituberculosis activity of CLA is inferior to those of INH and streptomycin. However, the activity of CLA when used alone or in combination was comparable to that of thiacetazone, indicating its potential usefulness as a secondary drug for the treatment of tuberculosis.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference17 articles.
1. Biehle J. R. and S. J. Cavalieri. 1993. Synergistic activity of clarithromycin and antituberculous drugs against multidrug-resistant M. tuberculosis abstr. U27. In Abstracts of the 93rd General Meeting of the American Society for Microbiology 1993. American Society for Microbiology Washington D.C.
2. Brown S. T. A. Shahidi and J. Jacobson. 1994. In vitro activity of clarithromycin in combination with ethambutol and rifampin against isolates of Mycobacterium tuberculosis abstr. U116. In Abstracts of the 94th General Meeting of the American Society for Microbiology 1994. American Society for Microbiology Washington D.C.
3. Synergistic activities of clarithromycin and antituberculous drugs against multidrugresistant Mycobacterium tuberculosis;Cavalieri S. J.;Antimicrob. Agents Chemother.,1995
4. Clarithromycin and other antimycobacterial agents in the treatment of disseminated Mycobacterium avium infections in patients with acquired immunodeficiency syndrome;Dautzenberg B.;Arch. Intern. Med.,1993
5. Activity of clarithromycin against Mycobacterium avium in patients with the acquired immune deficiency syndrome: a controlled clinical trial;Dautzenberg B.;Am. Rev. Respir. Dis.,1991
Cited by
44 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献